Company Filing History:
Years Active: 2025
Title: The Innovations of Abraham Friedman
Introduction
Abraham Friedman is a notable inventor based in West Hartford, Connecticut. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work has implications for treating various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Friedman holds a patent for "Methods of producing anti-C5 antibodies." This patent details a method for producing an anti-C5 antibody known as ravulizumab. The process involves culturing mammalian cells that contain a nucleic acid encoding the antibody in a specialized cell culture production medium. The method includes multiple purification and recovery steps, ensuring the antibody's efficacy and safety for therapeutic use.
Career Highlights
Abraham Friedman is currently associated with Alexion Pharmaceuticals, Inc., a leading company in the development of life-changing therapies for patients with rare diseases. His role at Alexion has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Friedman has worked alongside talented colleagues such as Hunter F. Malanson and Kyle A. Zingaro. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Abraham Friedman exemplifies the spirit of innovation in the biotechnology sector. His contributions, particularly in the production of therapeutic antibodies, highlight the critical role inventors play in advancing medical science.